Editorial. The prescription opioid abuse epidemic in rural America: A look at how it begins

Stacey C. Sigmon, PhD; Amanda G. Kennedy, PharmD

doi:10.5055/jom.2014.0210

Authors

Stacey C. Sigmon, PhD
Amanda G. Kennedy, PharmD

DOI:

https://doi.org/10.5055/jom.2014.0210

Keywords:

opioid, prescription opioid, treatment, rural, opioid dependence, buprenorphine

Abstract

No abstract.

Author Biographies

Stacey C. Sigmon, PhD

Stacey C. Sigmon, PhD, Department of Psychiatry, College of Medicine, University of Vermont, Burlington, Vermont.

Amanda G. Kennedy, PharmD

Amanda G. Kennedy, PharmD, Division of General Internal Medicine, Department of Medicine, College of Medicine, University of Vermont, Burlington, Vermont.

References

Maxwell JC: The prescription drug epidemic in the United States: A perfect storm. Drug Alcohol Rev. 2011; 30(3): 264-270.

Birnbaum HG, White AG, Schiller M, et al.: Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011; 12(4): 657-667.

Sigmon SC: Access to treatment for opioid dependence in rural America: Challenges and future directions. JAMA Psychiatry. 2014; 71(4): 359-360.

Office of National Drug Control Policy (ONDCP): Vermont drug control update. Available at http://www.whitehouse.gov/sites/default/files/docs/state_profile_-_vermont.pdf. Accessed April 16, 2014.

Sigmon SC, Dunn K, Saulsgiver K, et al.: A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers. JAMA Psychiatry. 2013; 70(12): 1347-1354.

Substance Abuse and Mental Health Services Administration: Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013.